Company: INMB
Filing Date: 2025-11-10
Form Type: 8-K
Source: 0001213900-25-108315
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-11-10
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
 ────────────────────────────────────────────────────────────────────────────────────────────────
         99.1      Investor Presentation                                                        
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                               INMUNE BIO INC.                               
  Date: November 10, 2025      By:                  /s/ David Moss           
                               Name:                David Moss               
                               Title:               Chief Executive Officer